CN Patent

CN119156384B — 苯并[c]色满化合物的多晶型及其制备方法和用途

Assigned to Ruishi Biomedical Co ltd · Expires 2025-12-09 · 0y expired

What this patent protects

本发明公开了苯并[c]色满化合物的多晶型及其制备方法和用途，具体提供了式I所示的化合物的多晶型及其制备方法和用途。式I所示的化合物作为组织蛋白酶C抑制剂，其晶型及含有晶型的药物组合物可用于治疗气喘、阻塞性肺病、支气管扩张、ANCA相关性血管炎、银屑病、α1‑抗胰蛋白酶缺乏症、狼疮性肾炎、糖尿病、炎症性肠病、风湿性关节炎、鼻窦炎、化脓性汗腺炎或癌症。

USPTO Abstract

本发明公开了苯并[c]色满化合物的多晶型及其制备方法和用途，具体提供了式I所示的化合物的多晶型及其制备方法和用途。式I所示的化合物作为组织蛋白酶C抑制剂，其晶型及含有晶型的药物组合物可用于治疗气喘、阻塞性肺病、支气管扩张、ANCA相关性血管炎、银屑病、α1‑抗胰蛋白酶缺乏症、狼疮性肾炎、糖尿病、炎症性肠病、风湿性关节炎、鼻窦炎、化脓性汗腺炎或癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN119156384B
Jurisdiction
CN
Classification
—
Expires
2025-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Ruishi Biomedical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.